Loading…
Loading…
SNNC does not currently pay a dividend.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for SNNC and 80,000+ other tickers.
See exactly how SNNC's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for SNNC and 80,000+ other tickers.
Sibannac, Inc. operates as a media and management services company. It serves businesses with online marketing, advertising, sales tracking, management consulting, and other informational services. The company also provides accounting, and expense and labor management systems to assist in compliance in the regulated industry environment. Sibannac, Inc. is based in Phoenix, Arizona.
Special Purpose Vehicle to Be Formed in Connection With Proposed Transaction PARADISE VALLEY, AZ / ACCESS Newswire / August 13, 2026 / Sibannac, Inc. (OTCID:SNNC), ("Sibannac" or the "Company"), a Nevada corporation focused on next-generation wellness solutions, today announced that it has entered into a non-binding Letter of Intent (the "LOI") with two strategic partners. Under the terms of the LOI, the parties intend to explore a potential business relationship, collaboration, and transaction centered on helping patients reach their maximum health potential through an expanding network of clinicians.
PARADISE VALLEY, AZ / ACCESS Newswire / May 20, 2026 / Sibannac, Inc. (OTCID:SNNC), a trailblazer in psychedelic and plant-medicine wellness solutions, is excited to announce the development and upcoming market launch of a new line of wellness products featuring Reishi and Lion's Mane mushrooms as well as Moringa. These offerings represent a strategic expansion designed to provide accessible, effective health solutions as part of Sibannac's commitment to holistic well-being.
PARADISE VALLEY, AZ / ACCESS Newswire / May 14, 2026 / Sibannac, Inc. (OTCID:SNNC), a trailblazer in psychedelic and plant-medicine wellness and therapeutic solutions, today announced the signing of a Letter of Intent (LOI) to form a joint venture with 1120 Management, LLC ("1120"), an Arizona-based licensed medical cannabis operator. The joint venture will develop and operate a dedicated, secure psilocybin research, cultivation, extraction, and analytical laboratory facility in Phoenix, Arizona.
SCOTTSDALE, AZ / ACCESS Newswire / April 23, 2026 / Sibannac, Inc. (OTCID:SNNC), a trailblazer in psychedelic tourism and plant-medicine experiences, welcomes President Trump's executive order accelerating federal research into ibogaine, MDMA, psilocybin and related compounds. Industry analysts and wellness travel operators predict a rapid expansion of a new niche: psychedelic-assisted wellness tourism tailored to veterans, law enforcement officers and first responders suffering from depression and PTSD.
SCOTTSDALE, AZ / ACCESS Newswire / April 1, 2026 / Sibannac, Inc. (OTCID:SNNC), a forward-moving company focused on growth, innovation, and market expansion, is proud to announce it has entered into a strategic marketing consulting agreement with Small Cap Access, a premier investor relations and market awareness firm known for delivering high-impact exposure and liquidity solutions for public companies. This engagement marks a pivotal step in Sibannac's mission to aggressively expand its market footprint, strengthen investor awareness, and accelerate revenue generation through strategic capital markets positioning.